Whipplewood Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.66K	Buy	45 +44	+4,400%	+$5.53K	﹤0.01%	670
2025 Q1	$4.98K	Sell	1 -44	-98%	-$219K	﹤0.01%	699
2024 Q4	$6.14K	Buy	+45	New	+$6.14K	﹤0.01%	649